Saturday, July 30, 2011
(recap-dated July 29, 2011) Gynecologic Cancers Update from the 2011 Annual Oncology Meeting « OncoFacts
abstract - European Journal of Obstetrics & Gynecology and Reproductive Biology : Ovarian cancer risk assessment: a tool for preoperative assessment
► Correct pre-operative diagnosis of ovarian cancer is key to referral.
► Surgery by gynecologic oncologist helps survival.
► Combination of age, prealbumin, CA 125 helps proper referral.
add your opinions Prealbumin; Transthyretin; CA 125; Ovarian neoplasms; Pelvic mass
DIA Patient Organization/ Advocate Track - Drug Information Association - conference notice Rare Diseases/Orphan Products Oct 11-13th Washington, Dc
|Patient Organization/ Advocate Track |
Note: requires registration (free)Interactive Case: Ovarian Cancer: Symptomatic Stage IV Disease Dr Thomas Herzog presents a provocative discussion focusing on options for treatment of a patient presenting with stage IV disease. His discussion incorporates the contemporary option of neo-adjuvant chemotherapy as well as the addition of an anti-angiogenic agent into the initial treatment regimen.
FDA Warns of Serious Drug Interactions in Patients Taking Psychiatric Drugs « news@JAMA (Linezolid/Zyvox/Methylene blue)
"Patients taking certain psychiatric drugs may experience serious neurological problems if they are given the antibacterial medication linezolid (sold under the brand name Zyvox) or methylene blue, a drug that is also used as a dye in some diagnostic procedures and for certain other uses, such as treating cyanide poisoning, according to a pair of warnings issued yesterday by the US Food and Drug Administration (FDA)."
Wiki Methylene blue resource: